Free Trial
ASX:ABP

Abacus Property Group (ABP) Stock Price, News & Analysis

Abacus Property Group logo

About Abacus Property Group Stock (ASX:ABP)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
1.45 million shs
Average Volume
N/A
Market Capitalization
A$1.05 billion
P/E Ratio
41.35
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive ABP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Abacus Property Group and its competitors with MarketBeat's FREE daily newsletter.

ABP Stock News Headlines

Citi Sticks to Its Buy Rating for Abacus Property Group (ABG)
Abacus Property Group (ABG) Receives a Buy from Shaw and Partners
Think you missed gold’s boom? Think again
If you've been watching gold's historic run and wondering if it's too late… I've got good news. Because there's a $15 fund tied directly to gold's surge that's still paying massive income… Up to 64% annually — with payouts every 30 days.
Citi Remains a Buy on Abacus Property Group (ABG)
Simon Property Group Inc
See More Headlines

ABP Stock Analysis - Frequently Asked Questions

Abacus Property Group (ASX:ABP) announced its quarterly earnings results on Thursday, August, 16th. The company reported $0.32 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.31 by $0.01. Abacus Property Group had a net margin of 17.33% and a trailing twelve-month return on equity of 0.74%.

Based on aggregate information from My MarketBeat watchlists, some other companies that Abacus Property Group investors own include Allena Pharmaceuticals (ALNA), Alpine Immune Sciences (ALPN), ARAVIVE (ARAV), Athersys (ATHX), Atara Biotherapeutics (ATRA), Autolus Therapeutics (AUTL) and Brainstorm Cell Therapeutics (BCLI).

Company Calendar

Last Earnings
8/16/2018
Today
7/12/2025

Industry, Sector and Symbol

Stock Exchange
ASX
Industry
REIT - Diversified
Sub-Industry
N/A
Current Symbol
ASX:ABP
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
A$0.33
Trailing P/E Ratio
41.35
Forward P/E Ratio
N/A
P/E Growth
7.18
Net Income
A$286.84 million
Net Margins
17.33%
Pretax Margin
N/A
Return on Equity
0.74%
Return on Assets
1.97%

Debt

Debt-to-Equity Ratio
29.94
Current Ratio
2.63
Quick Ratio
1.60

Sales & Book Value

Annual Sales
A$333.62 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
10.97
Book Value
A$3.76 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
893,660,000
Free Float
N/A
Market Cap
A$1.05 billion
Optionable
Not Optionable
Beta
0.91
A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report

This page (ASX:ABP) was last updated on 7/12/2025 by MarketBeat.com Staff
From Our Partners